Literature DB >> 34374777

Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease.

Anarmaa Mendsaikhan1, Ikuo Tooyama1, Geidy E Serrano2, Thomas G Beach2, Douglas G Walker1,3.   

Abstract

Alzheimer disease (AD) is a progressive neurodegenerative disease causing cognitive decline in the aging population. To develop disease-modifying treatments, understanding the mechanisms behind the pathology is important, which should include observations using human brain samples. We reported previously on the association of lysosomal proteins progranulin (PGRN) and prosaposin (PSAP) with amyloid plaques in non-demented aged control and AD brains. In this study, we investigated the possible involvement of PGRN and PSAP in tangle formation using human brain tissue sections of non-demented aged control subjects and AD cases and compared with cases of frontotemporal dementia with granulin (GRN) mutations. The study revealed that decreased amounts of PGRN and PSAP proteins were detected even in immature neurofibrillary tangles, while colocalization was still evident in adjacent neurons in all cases. Results suggest that neuronal loss of PGRN preceded loss of PSAP as tangles developed and matured. The GRN mutation cases exhibited almost complete absence of PGRN in most neurons, while PSAP signal was preserved. Although based on correlative data, we suggest that reduced levels of PGRN and PSAP and their interaction in neurons might predispose to accumulation of p-Tau protein.
© 2021 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Neuropathology; Progranulin; Prosaposin; Tangles

Mesh:

Substances:

Year:  2021        PMID: 34374777      PMCID: PMC8433593          DOI: 10.1093/jnen/nlab056

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.148


  61 in total

1.  A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation.

Authors:  H Hulková; M Cervenková; J Ledvinová; M Tochácková; M Hrebícek; H Poupetová; A Befekadu; L Berná; B C Paton; K Harzer; A Böör; F Smíd; M Elleder
Journal:  Hum Mol Genet       Date:  2001-04-15       Impact factor: 6.150

2.  Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.

Authors:  Keith A Josephs; Zeshan Ahmed; Omi Katsuse; Joseph F Parisi; Bradley F Boeve; David S Knopman; Ronald C Petersen; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Ryan J Uitti; Rosa Rademakers; Jennifer Adamson; Matthew Baker; Michael L Hutton; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2007-02       Impact factor: 3.685

Review 3.  Evolution of neuronal changes in the course of Alzheimer's disease.

Authors:  H Braak; E Braak
Journal:  J Neural Transm Suppl       Date:  1998

4.  Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.

Authors:  Hideyuki Takahashi; Zoe A Klein; Sarah M Bhagat; Adam C Kaufman; Mikhail A Kostylev; Tsuneya Ikezu; Stephen M Strittmatter
Journal:  Acta Neuropathol       Date:  2017-01-09       Impact factor: 17.088

5.  Increased caspase activation and decreased TDP-43 solubility in progranulin knockout cortical cultures.

Authors:  Gernot Kleinberger; Hans Wils; Peter Ponsaerts; Geert Joris; Jean-Pierre Timmermans; Christine Van Broeckhoven; Samir Kumar-Singh
Journal:  J Neurochem       Date:  2010-09-24       Impact factor: 5.372

6.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

Authors:  M Goedert; C M Wischik; R A Crowther; J E Walker; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Prosaposin is a regulator of progranulin levels and oligomerization.

Authors:  Alexandra M Nicholson; NiCole A Finch; Marcio Almeida; Ralph B Perkerson; Marka van Blitterswijk; Aleksandra Wojtas; Basar Cenik; Sergio Rotondo; Venette Inskeep; Laura Almasy; Thomas Dyer; Juan Peralta; Goo Jun; Andrew R Wood; Timothy M Frayling; Christian Fuchsberger; Sharon Fowler; Tanya M Teslovich; Alisa K Manning; Satish Kumar; Joanne Curran; Donna Lehman; Goncalo Abecasis; Ravindranath Duggirala; Cyril Pottier; Haaris A Zahir; Julia E Crook; Anna Karydas; Laura Mitic; Ying Sun; Dennis W Dickson; Guojun Bu; Joachim Herz; Gang Yu; Bruce L Miller; Shawn Ferguson; Ronald C Petersen; Neill Graff-Radford; John Blangero; Rosa Rademakers
Journal:  Nat Commun       Date:  2016-06-30       Impact factor: 14.919

9.  Progranulin deficiency leads to reduced glucocerebrosidase activity.

Authors:  Xiaolai Zhou; Daniel H Paushter; Mitchell D Pagan; Dongsung Kim; Mariela Nunez Santos; Raquel L Lieberman; Herman S Overkleeft; Ying Sun; Marcus B Smolka; Fenghua Hu
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

10.  Proximity ligation assay reveals both pre- and postsynaptic localization of the APP-processing enzymes ADAM10 and BACE1 in rat and human adult brain.

Authors:  Jolanta L Lundgren; Lina Vandermeulen; Anna Sandebring-Matton; Saheeb Ahmed; Bengt Winblad; Monica Di Luca; Lars O Tjernberg; Elena Marcello; Susanne Frykman
Journal:  BMC Neurosci       Date:  2020-02-04       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.